UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035712
Receipt number R000040650
Scientific Title Bladder cancer prospective cohort study on high-risk non-muscle invasive cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor(BRIGHT study)
Date of disclosure of the study information 2019/02/01
Last modified on 2020/08/26 19:23:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Bladder cancer prospective cohort study on high-risk non-muscle invasive cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor(BRIGHT study)

Acronym

BRIGHT study

Scientific Title

Bladder cancer prospective cohort study on high-risk non-muscle invasive cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor(BRIGHT study)

Scientific Title:Acronym

BRIGHT study

Region

Japan


Condition

Condition

non-muscle invasive bladder cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy of first PDD-TUR for high risk non-muscle invasive bladder cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Tumor residual rate

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients with first PDD-TUR
2)Patients with high risk Non-muscle Invasive Bladder Cancer(NMIBC)
3)Patients with 2nd TURBT within two month after first PDD-TUR
4)Patients with age between 20 years and under 90 year
5)Patients with ECOG Performance Status of 0-1
6)Patients with own disease information
7)Patients can provide written informed consent for study participation.

Key exclusion criteria

1)Patients with incomplete resection on first PDD-TUR
2)Patients with pT2 or Extensive CIS
3)Patients with previously enrolled in this study
4)Patients determined to be ineligible for this clinical study by research attending physician

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hideyasu
Middle name
Last name Matsuyama

Organization

Yamaguchi University Graduate School of Medicine

Division name

Department of Urology

Zip code

753-8511

Address

Minamikogushi1-1-1, Ube, Yamaguchi, Japan

TEL

0836-22-2275

Email

hidde@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Seiji
Middle name
Last name Yano

Organization

Yamaguchi University Graduate School of Medicine

Division name

Department of Urology

Zip code

753-8511

Address

1-1-1, Minamikogushi, Ube, Yamaguchi, Japan

TEL

0836-22-2275

Homepage URL


Email

syano@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

CHUGAI PHARMACEUTICAL CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board Yamaguchi University Hospital

Address

1-1-1, Minamikogushi, Ube, Yamaguchi, Japan

Tel

0836-22-2428

Email

clin_res@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山口大学医学部附属病院(山口県)
高知大学医学部附属病院(高知県)
奈良県立医科大学付属病院(奈良県)
埼玉医科大学国際医療センター(埼玉県)
浜松医科大学医学部附属病院(静岡県)
大阪医科大学付属病院(大阪府)
筑波大学付属病院(茨城県)
神戸市立医療センター(兵庫県)
東京大学医学部附属病院(東京都)
金沢大学付属病院(石川県)
弘前大学医学部付属病院(青森県)
山梨大学医学部付属病院(山梨県)
北海道大学病院(北海道)


Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 11 Month 13 Day

Date of IRB

2018 Year 11 Month 28 Day

Anticipated trial start date

2018 Year 12 Month 01 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective study


Management information

Registered date

2019 Year 01 Month 29 Day

Last modified on

2020 Year 08 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040650


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name